Larry Cuellar Adult Viral Hepatitis Prevention Coordinator Texas Department of State Health Services 2010 STREET OUTREACH WORKERS CONFERENCE June 21, 2010.

Slides:



Advertisements
Similar presentations
Strategies and Interventions for Community-Based Organizations Implementing HIV Prevention Joseph Prejean, Ph. D. Capacity Building Branch Division of.
Advertisements

State of Texas HIV Planning &. Goals for the National HIV/AIDS Strategy 1.Reduce new HIV infections 2.Increase access to care and improve health outcomes.
Out of Sight, Out of Time: Injection Drug Users, Hepatitis C, and HIV Policy Daniel Raymond Hepatitis C Policy Analyst Harm Reduction Coalition
Perinatal Hepatitis B Prevention
Nationals HIV/AIDS Strategy and how the mission of Women Accepting Responsibility, Inc. is helping to meet this goal. By She’kell Hutchinson Program Director,
Hepatitis C In Alaska’s Department of Corrections
Edo Agustian Indonesian Drug Users Network Experiencing HCV Infection – the treatment, the reality and the possibilities for Cure.
Hepatitis and Liver Cancer A National Strategy for Prevention and Control of Hepatitis B and C.
STI Prevention & Control Programs Local and State M. Terry Hogan, MPH STD/HIV Prevention Training Center at JH June 9, 2014 National Center for HIV/AIDS,
Incorporating HIV and Viral Hepatitis Testing and Referral into Idaho Drug Court Programs Presented by Idaho Advisory Council on HIV and AIDS, Bebe Thompson,
Kevin Fenton, MD, PhD, FFPH Director, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Centers for Disease Control and Prevention.
Chronic Hepatitis B Surveillance Kathleen Harriman California Department of Public Health Immunization Branch November 1, 2012.
Routine HIV Screening in Health Care Settings David Spach, MD Clinical Director Northwest AIDS Education and Training Center Professor of Medicine, Division.
A Webinar Hosted by The National Harm Reduction Coalition The National Black Leadership Commission on AIDS The Coalition for Positive Health Empowerment.
HIV/AIDS Treatment and Care Clinical protocols for the WHO European Region 23 November 2007 World AIDS Day Jeffrey V. Lazarus WHO Europe, STI/HIV/AIDS.
Guidance on Provider-initiated Voluntary Medical Examination, Testing and Counselling for Infectious Diseases in Injecting Drug Users Hans Blystad 1 and.
Module 3: HCV prevalence and course of HCV infection.
Hepatitis C Education & Awareness. Women In Government Women In Government Foundation, Inc. is a national, non-profit, non-partisan organization of women.
Adult Viral Hepatitis Update Roxanne Ereth, MPH, BS Hepatitis C Program Manager Adult Viral Hepatitis Prevention Coordinator.
Unit 1: Overview of HIV/AIDS Case Reporting #6-0-1.
HIV/AIDS STI & Viral Hepatitis WHO/Europe HIV/HCV coinfection in Europe Dr Irina Eramova August 4, 2008 XVII International AIDS Conference, Mexico.
HBV and HCV: America’s Hidden Epidemics Jeffrey Levi, PhD Trust for America’s Health October 14, 2010.
Working with SEPs: How do we expand Hepatitis Services ? Narelle Ellendon, RN HCV Director Harm Reduction Coalition, NYC
Program Collaboration and Service Integration: An NCHHSTP Green paper Kevin Fenton, M.D., Ph.D., F.F.P.H. Director National Center for HIV/AIDS, Viral.
HIV/AIDS prevention and care among injecting drug users and in prison settings in Estonia, Latvia and Lithuania Signe ROTBERGA UNODC, Baltic States 5 November.
Mental Health and Substance Abuse Services Joe Vesowate Assistant Commissioner.
Prevention and Control of Viral Hepatitis Infection: WHO Framework for Global Action Prevention and Control of Viral Hepatitis Infection: WHO Framework.
RCGP training online: new training in short bites Danny Morris, Expert Lead RCGP Hepatitis B and C Part 1.
Safe Immunization Practices and Prevention of Hepatitis B and C Susan Mackay Behaviour Change Project Safe Injection Global Network.
Division of HIV/AIDS Prevention CDC-RFA-PS
Alliance Discussion with Office of AIDS: November HIV/AIDS Surveillance Surveillance overview HIV Incidence Surveillance Second Surveillance Stakeholder.
The Minority AIDS Initiative (MAI): Then and Now Edwin M. Craft, Dr. P
Gustavo Aquino, MPH Associate Director for Program Integration National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention Program Collaboration.
1 Journal Club Alcohol, Other Drugs, and Health: Current Evidence March–April 2012.
Sarah Weninger Adult Viral Hepatitis Prevention Coordinator Division of Disease Control Phone:
State and Local STD Prevention Programs Prepared by Jim Lee, Senior Public Health Advisor, Texas Department of State Health Services and Melinda Salmon,
Welcome to “STD 101 in a Box” Developed by Centers for Disease Control and Prevention National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention.
Affordable Care Act: Implications for Public Health Marty Fenstersheib, MD, MPH Health Officer Santa Clara County.
TB, STDs, HIV, HEPATITIS C and SUBSTANCE ABUSE: A Local Perspective Paula Kriner, MPH Imperial County Public Health Department Management of TB, STDs,
Introduction to NCHHSTP National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Office of the Director Jonathan Mermin, MD, MPH National.
Pennsylvania: The State of HCV 2015
Integration of HIV/AIDS, STD, TB and Viral Hepatitis New York State’s Experience Guthrie S. Birkhead, M.D., M.P.H. Director, AIDS Institute Director, Center.
Injection Drug Use and Hepatitis C What Can We Do About It? Wilson M. Compton, M.D., M.P.E. Deputy Director National Institute on Drug Abuse.
Hepatitis C: The Silent Epidemic Wednesday, October 21, 2015 John W. Ward, M.D. Division of Viral Hepatitis Centers for Disease Control and Prevention.
PERSPECTIVES FROM THE FIELD DR LYDIA MUNGHERERA TASO (The Aids Support Organisation) UGANDA REVERSING THE TIDE OF TB.
1 MSM Sexual Health Summit August 20, 2012 HIV/STD Prevention and Care Branch Texas Department of State Health Services.
Integration of collaborative TB/HIV activities with harm reduction services Maryna Zelenskaya Ph D State service on HIV/AIDS and other socially diseases.
Alcohol and AIDS: A New Decade Grantsmanship Workshop XIX International AIDS Conference Rome, Italy Kendall J. Bryant, Ph.D., NIAAA Alcohol and AIDS Research.
California Department of Public Health Office of AIDS HIV CARE and PREVENTION 2009: You Need to Know.
Organizing Drug Users for Public Health Policy Changes 17 th International Conference on the Reduction of Drug Related Harm Jason Farrell, Executive Director.
Universal Opt-Out Screening for HIV in Health Care Settings, Cost Effectiveness in Action Douglas K. Owens, MD, MS VA Palo Alto Health Care System and.
| Web: The findings and conclusions in this report are those of the authors and do not necessarily represent the official.
Edo Agustian Indonesian Drug Users Network Meaningful Involvement of PWID in Hep C advocacy in Indonesia.
Non-Medical Staff Knowledge, Beliefs and Practices about HIV and Hepatitis for Injection Drug Users Rowe, KA 1, Tesoriero, JM 1, Heavner, KK 1, Rothman,
Federal Welcome: A View from the Office of HIV/AIDS and
Hepatitis C Virus Program in Chicago
Pengjun Lu, PhD, MPH;1 Kathy Byrd, MD, MPH;2
Addressing the Intersection of Substance Abuse and Viral Hepatitis
Integrating Hepatitis into the World of Community Planning
Hepatitis C Allies of Philadelphia August 2, 2017
Collaborations/Coordination
Hepatitis C Incidence and Prevalence in the U.S.
Summary Report: Management of Hepatitis C in Prisons
Viral Hepatitis in Correctional Settings
Jonathan Mermin, MD, MPH RADM, USPHS
Viral Hepatitis Prevention Project (VHPP) in Massachusetts
HCV Screening.
Implementing New ACIP Adult Hepatitis B Vaccine Recommendations Eric E
Progress in Facilitating National HCV Prevention
March 8, 2006 New ACIP Hepatitis B Recommendations
Presentation transcript:

Larry Cuellar Adult Viral Hepatitis Prevention Coordinator Texas Department of State Health Services 2010 STREET OUTREACH WORKERS CONFERENCE June 21, 2010 Austin, Texas The State of Hepatitis in the State of Texas: A Comparison of Activities with the Viral Hepatitis National Plan

 Why is the IOM Report is so important?  What does this have to do with me?  What are the findings and recommendations?  How are we doing in the state?

Issues IOM was asked to address  Strategies for preventing HBV and HCV infections  Strategies for reducing morbidity and mortality from chronic HBV and HCV infections  Assess the type and quality of data needed from state and local viral hepatitis surveillance systems to guide and evaluate prevention services

 Chronic viral hepatitis is ◦ a serious public health problem in the U.S. ◦ poorly understood by providers, public, and policy makers  Lack of awareness and knowledge results in ◦ Missed opportunities for prevention  Inadequate investments in viral hepatitis services and care

The Current Situation  Hepatitis B virus (HBV) 800,000 to 1.4 million people are chronically infected with HBV in United States  3,000 deaths each year are due to hepatitis B-related liver disease  Hepatitis C virus (HCV) million people are chronically infected with hepatitis C virus (HCV) in United States  12,000 deaths each year are due to hepatitis C-related liver disease  Over 150,000 deaths due to hepatitis B and hepatitis C are projected to occur in next 10 years

The Issues by Comparison VirusPrevalence% of Population Unaware of Infection Status Deaths in 2006 Related to Infection HBV800,000 –1.4 million About 65%3,000 HCV2.7–3.9 millionAbout 75%12,000 HIV1.1 millionAbout 21%14,016 Sources: CDC; Lin et al, 2007; Hagan et al 2006

Populations at increased risk Asian/Pacific Islanders – in the US, 1 out of 10 API are chronically infected with hepatitis B Injecting Drug Users – 60% - 90% of IDUs are infected with hepatitis C What are some of the other populations at high risk?

Lack of Public Awareness Lack of Provider Awareness Lack of Public Resource Allocation Morbidity and Mortality related to hepatitis B and hepatitis C  At-risk people do not know how to prevent becoming infected  At-risk people may not have access to preventive services  Chronically infected people do not know that they are infected  Providers do not screen people  Providers do not know how to manage infected patients  Inadequate access to testing and medical management  Inadequate disease-surveillance systems

Domestic HIV 69% TB 14% STD 15% National Center for HIV/AIDS, Viral Hepatitis, Sexually Transmitted Disease, and Tuberculosis Prevention Funding $1 Billion Total Hepatitis 2% Source: CDC The Fiscal Issues

Lack of Public Awareness Lack of Provider Awareness Lack of Public Resource Allocation Morbidity and Mortality related to hepatitis B and hepatitis C The Consequences Improved Provider and Community Education Integration and Enhancement of Viral Hepatitis Services Improved Immunization Improved Disease Surveillance

Recommendation: Surveillance IOM REPORT:  CDC should develop specific cooperative agreements to support core surveillance for acute and chronic HBV and HC  CDC should support and conduct active surveillance to monitor incidence and prevalence of hepatitis B and C infections in populations not fully captured by core surveillance.

Current Hepatitis Surveillance Activities in Texas  What does the state require to be reported to the health department regarding hepatitis infection? Hepatitis A, B, C, D, E (acute) Hepatitis B (acute and chronic) identified prenatally or at delivery

Recommendation: Improved Provider Education IOM REPORT:  CDC should work with key stakeholders to develop hepatitis B and C educational programs for health-care and social-service providers.  CDC should work with key stakeholders to develop hepatitis B and C educational programs for target at-risk populations and the general public.

DSHS Activities  Convene two annual meetings, Hepatitis Summits, to raise awareness and education ◦ Houston, April 16, 2010 ◦ Austin, October 22, 2010  Course on the Basics of Hepatitis available on TRAIN Texas website. ◦ Four hour training ◦ Covers hepatitis A, B and C

Recommendation: Immunization IOM REPORT:  Ensure the recommendations of the Advisory Committee on Immunization practice be in effect for all infants.  CDC should work with key stakeholders to ensure hepatitis B vaccine series is as a requirement for school attendance.  Additional resources should be devoted to increasing hepatitis B vaccine of at-risk adults.

Adult Hepatitis B Vaccination Initiative

DSHS Clinical Standards  STD program operating procedures contain an expectation that all STD clinics will provide routine Hepatitis A and B immunizations to all unimmunized patients, regardless of risk factors.  HIV care entities should have a similar expectation.

Recommendation: Viral Hepatitis Services IOM REPORT:  Federally funded health-insurance programs should incorporate guidelines for risk-factor screening for hepatitis B and C and infected patients should received appropriate medical management.

Expansion of Hepatitis C Testing  In 2010, went from 11 HIV counseling and testing sites to 16 sites.  Working to expand to substance abuse sites conducting HIV testing.  Working to expand to sites in Houston.

Barriers to Hepatitis C Testing No financial resources available for hepatitis C testing. No resources available for confirmatory testing. No treatment available for those that test positive. Not my job, don’t pay me to do this, just one more thing I have to do…

HCV Disease Progression Progression of HCV Monoinfection Over Years These numbers are rough estimates based on people with HCV only. Cofactors like HIV infection or alcohol use increase the risk of disease progression.

Texas Hepatitis Network The Texas Hepatitis Network was created in response to the community’s need for a place to exchange hepatitis resources and information for Texans. As part of this community we have created an interactive resource map for you.

Recommendation: Viral Hepatitis Services IOM REPORT:  CDC should work with key stakeholders to expand programs to reduce the risk of hepatitis C infection through injection-drug use, at minimum programs should include access to sterile syringes and drug-prep equipment.

Recommendation: Viral Hepatitis Services IOM REPORT:  CDC and HRSA should provide resources and guidance to integrate comprehensive services into settings serving high-risk populations.

Facilities Providing On-site Infectious Disease Screening: 2007 Source: 2007 SAMHSA National Survey of Substance Abuse Treatment Services (N-SSATS).

Comprehensive viral hepatitis services consist of five core components:  Community outreach and awareness  Vaccination and harm reduction  Identification of infected people  Social and peer support  Medical management Box 5-3 pg 126

HCV and HIV Coinfection  Up to 240,000 people in the U.S. are co-infected with HIV/HCV  Majority have chronic disease (85%)  1/3 of HIV+ people are co-infected with HCV  10% of HCV+ people are co-infected with HIV  In urban areas, up to 90% of HIV+ IDUS are co-infected with HCV

Potential Co-infection Effect of HIV on HCV Disease  HIV infection may worsen HCV disease  Weakened immune system allows HCV to replicate faster  More infectious because higher viral load  Accelerates and increases disease progression  May not respond well to HCV treatment

Potential Co-Infection Effect of HCV on HIV Disease  HCV disease does not appear to accelerate HIV disease  Higher toxicity from HAART  As people live longer with HIV, many more HIV deaths are caused by HCV-related end stage liver disease  There is still a lot of research to be done on these effects

Cancer-A-National-Strategy-for-Prevention-and- Control-of-Hepatitis-B-and-C.aspx